Full access
APA Institute
Published Online: 15 July 2005

Forum Will Help Psychiatrists Explain Medicare Part D

Ellen JaffeAuthors Info & Affiliations
Publication: Psychiatric News
Volume 40, Number 14
https://doi.org/10.1176/pn.40.14.00400028c
Aforum that will provide APA members with the practical information they need to help their patients navigate Medicare's new Part D pharmaceutical benefit has been added to the schedule of APA's 2005 Institute on Psychiatric Services.
The institute will be held in San Diego from October 5 to 9 (see above box for registration information).
The forum, “Readying for the New Medicare Pharmacy Benefit: The Part D Challenge,” will be sponsored by APA's Office of Healthcare Systems and Financing and chaired by Director Irvin “Sam” Muszynski. It is part of APA's ongoing effort to educate members about Medicare's new prescription drug benefit, which begins on January 1, 2006.
The forum will be held on Friday, October 7, at 10 a.m.
Said Muszynski, “Deciding which Part D pharmacy plan to participate in will be a daunting task for almost all Medicare beneficiaries, but especially for dual-eligible beneficiaries, whose drug benefit will be transferred from their state's Medicaid program to Medicare. We anticipate that patients will be very dependent on their physicians to help them make the right decision.
“Although the implementation timeline of Part D is in place, the details are still being worked out by the Centers for Medicare and Medicaid Services. We're hoping that by October 7 we'll have more hard information to provide to IPS attendees.”
Part D will be administered by commercial prescription drug plans (PDPs). Beneficiaries will be able to select the plan that they believe best meets their needs beginning on November 15.
Starting in late October, dual-eligible beneficiaries will be enrolled automatically in one of the PDPs in their region with the lowest premiums. Although they have the right to switch to another plan with an equivalent premium prior to January 1, 2006, their ability to do so greatly concerns patient advocates, given the amount and complexity of information that must be considered in selecting a plan. ▪

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 40 • Number 14 • July 15, 2005
Pages: 28

History

Published online: 15 July 2005
Published in print: July 15, 2005

Notes

Psychiatrists will learn the nuts and bolts of the new Medicare Part D drug benefit so that they can help their patients select the plan that best fits their needs.

Authors

Affiliations

Ellen Jaffe
Ellen Jaffe is the Medicare specialist in APA's Office of Healthcare Systems and Financing.
View all articles by this author

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.